Methylene blue, an Hsp70 ATPase inhibitor, reduced cell migration by inhibiting matrix metalloproteinase (MMP)-2 activation in MDA-MB-231 breast cancer cells [81]. This evidence concerns the gene DNAH8 and breast carcinoma.